The tweet was deleted by the author.
But we saved everything 🙂.
Centene reported that after a life‑altering injury, Allison lost a sense of control over her daily life.
Through Self-Directed Care from Buckeye Health, Allison was able to take a more active role in her support and daily routine.
CNC is trading well below the key MA-20 ($37.24), MA-50 ($40.54), and MA-200 ($37.37), signaling persistent downward pressure across short-, medium-, and long-term timeframes. The Ichimoku Kijun on D1 is at $38.49, which stands as immediate resistance above the current price. For near-term support, watch the MA-5/EMA-5 cluster around $32.81–$33.03, while key support sits near the MA-200 at $37.37. Immediate resistance aligns closely with the Ichimoku Kijun at $38.49, with key resistance at MA-50 ($40.54).
Momentum readings remain bearish, as MACD on D1 signals further declines and ADX shows a sell bias with moderate trend strength. RSI sits at 29.55 and the Stoch RSI reads oversold, both highlighting stretched downside conditions. CCI confirms an oversold setup, while BBP at –1.21 shows sellers dominate intraday momentum. AO on D1 aligns with the prevailing sell trend. CNC has fallen $2.39 (6.95%) over the past week, down sharply from the previous close of $34.37 and sitting at the very bottom of its weekly range, reflecting a decisive move lower. Weekly volatility stands at 9.47%, and the tone is a firm and steady decline from the highs. In today's session, the price slipped 4.71%, underscoring strong downward momentum.
Looking ahead, the expected trading range for CNC next week is estimated at $31.50 to $33.50, keeping the forecast realistic and consistent with recent volatility. Given that all W1 momentum indicators (RSI, ADX, MACD, MA-50) indicate sell or neutral, the probability of a price increase is very low (less than 20%), while a further decline is more likely. The baseline scenario sees CNC consolidating sideways near support, as oversold oscillators may temporarily slow further losses. A bullish scenario would require a recovery above $33.50, opening the way for a test of resistance near $37.24. A bearish break below $31.50 would expose the region near the 52-week low of $25.08. This entire forecast sits much closer to the yearly bottom than the high ($66.03), indicating enduring downside pressure.
Previously it was reported that Centene Corporation advanced its focus on community health by investing in affordable housing projects in Chicago. As the company's strategic initiatives continue to evolve, a key level to watch will be how further expansion into social impact programs might influence both shareholder sentiment and long-term growth prospects.